Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | GDC-7035 |
| Synonyms | |
| Therapy Description |
GDC-7035 inhibits KRAS G12D, potentially resulting in decreased growth of tumor cells overexpressing KRAS G12D (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| GDC-7035 | GDC7035|GDC 7035|RG 6620|RG-6620|RG6620 | KRAS G12D Inhibitor 25 | GDC-7035 inhibits KRAS G12D, potentially resulting in decreased growth of tumor cells overexpressing KRAS G12D (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06619587 | Phase Ib/II | GDC-7035 | A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors | Recruiting | USA | ISR | GBR | ESP | CAN | AUS | 2 |